Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C9H15NO3 |
Molecular Weight | 185.2203 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1[C@H]2CC[C@@H]1[C@H]([C@@H](O)C2)C(O)=O
InChI
InChIKey=PHMBVCPLDPDESM-FKSUSPILSA-N
InChI=1S/C9H15NO3/c1-10-5-2-3-6(10)8(9(12)13)7(11)4-5/h5-8,11H,2-4H2,1H3,(H,12,13)/t5-,6+,7-,8+/m0/s1
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs. | 1997 Sep |
|
Synthesis and dopamine transporter binding of 2beta-isopropyl ester analogs of cocaine. | 2002 Feb |
|
Determination of cocaine, its metabolites, pyrolysis products, and ethanol adducts in postmortem fluids and tissues using Zymark automated solid-phase extraction and gas chromatography-mass spectrometry. | 2004 Jul 5 |
|
Gender differences in cocaine pharmacokinetics in CF-1 mice. | 2005 Jan 15 |
|
Concentration profiles of cocaine, pyrolytic methyl ecgonidine and thirteen metabolites in human blood and urine: determination by gas chromatography-mass spectrometry. | 2005 Nov |
|
Simultaneous analyses of cocaine, cocaethylene, and their possible metabolic and pyrolytic products. | 2006 Feb 10 |
|
Rapid analysis of benzoylecgonine in urine by fast gas chromatography-mass spectrometry. | 2006 Oct |
|
Cocaine profiling for strategic intelligence purposes, a cross-border project between France and Switzerland. Part I. Optimisation and harmonisation of the profiling method. | 2007 Apr 11 |
|
Bioanalytical procedures for determination of drugs of abuse in blood. | 2007 Aug |
|
Cocaine and metabolites urinary excretion after controlled smoked administration. | 2007 Oct |
|
Abstracts of papers presented at the 2008 pittsburgh conference. | 2008 |
|
Alpha2-containing GABA(A) receptors are involved in mediating stimulant effects of cocaine. | 2008 Jul |
|
Tropane alkaloids as medicinally useful natural products and their synthetic derivatives as new drugs. | 2008 Jul-Aug |
|
Identification of metabolites with anticancer properties by computational metabolomics. | 2008 Jun 17 |
|
Application of discriminant analysis to differentiate between incorporation of cocaine and its congeners into hair and contamination. | 2008 Mar 21 |
|
An automated SPE/LC/MS/MS method for the analysis of cocaine and metabolites in whole blood. | 2008 Oct 15 |
|
Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine. | 2009 Apr 28 |
|
Can cocaine use be evaluated through analysis of wastewater? A nation-wide approach conducted in Belgium. | 2009 May |
|
The hydrated and anhydrous gold(III) tetrachloride salts of L-ecgonine, an important forensic toxicology marker for cocaine. | 2010 Jan |
|
Urinary excretion of ecgonine and five other cocaine metabolites following controlled oral, intravenous, intranasal, and smoked administration of cocaine. | 2010 Mar |
|
Quantification of drugs of abuse in municipal wastewater via SPE and direct injection liquid chromatography mass spectrometry. | 2010 Nov |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
9180
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
207-565-4
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
PRIMARY | |||
|
DB01525
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
PRIMARY | |||
|
ECGONINE
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
PRIMARY | |||
|
C005617
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
PRIMARY | |||
|
DTXSID701019899
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
PRIMARY | |||
|
91460
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
PRIMARY | |||
|
4743
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
PRIMARY | |||
|
481-37-8
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
PRIMARY | |||
|
DX2E9E17AV
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
PRIMARY | |||
|
m4810
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB33203
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
PRIMARY | |||
|
100000126157
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
PARENT (SALT/SOLVATE)
PARENT (SALT/SOLVATE)
PARENT (SALT/SOLVATE)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)